Literature DB >> 26680107

Protective effect of thymol on high fat diet induced diabetic nephropathy in C57BL/6J mice.

Settu Saravanan1, Leelevinothan Pari2.   

Abstract

Obesity is one of several factors implicated in chronic kidney disease (CKD). Thymol, a monoterpene phenolic compound found in the oils of thyme with multiple biological properties especially antidiabetic activity. The present study was undertaken to evaluate the thymol against diabetic nephropathy by high fat diet (HFD)-induced diabetic C57BL/6J mice. After 10 weeks of continuous dietary intervention, HFD (fat- 35.2%) to mice presented characteristic features of progressive nephropathy by significant increased in kidney weight, blood, and urinary parameters, glomerulosclerosis, oxidative stress, hyperlipidemia and subsequent renal injuries. After intragastric administration of thymol (40 mg/kg BW) daily for the subsequent 5 weeks significantly decreased the blood, urinary parameters and kidney weight. Thymol inhibited the activation of transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF). Also, significantly increased the antioxidants and suppresses the lipid peroxidation markers in erythrocytes and kidney tissue compared to the diabetic mice. Thymol downregulated the expression level of sterol regulatory element binding protein-1c (SREBP-1c) and reduced the lipid accumulation in renal. Histopathological study of kidney tissues showed that extracellular mesangial matrix expansion, glomerulosclerosis in diabetic mice were suppressed by thymol. Further, our results indicate that administration of thymol afforded remarkable protection against HFD-induced diabetic nephropathy.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Diabetic nephropathy; Glomerulosclerosis; High fat diet; Lipids; Thymol

Mesh:

Substances:

Year:  2015        PMID: 26680107     DOI: 10.1016/j.cbi.2015.11.033

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  14 in total

1.  Thymol improves high-fat diet-induced cognitive deficits in mice via ameliorating brain insulin resistance and upregulating NRF2/HO-1 pathway.

Authors:  Hongyan Li; Tingting Qin; Min Li; Shiping Ma
Journal:  Metab Brain Dis       Date:  2016-10-20       Impact factor: 3.584

2.  Investigation of thymol effect on learning and memory impairment induced by intrahippocampal injection of amyloid beta peptide in high fat diet- fed rats.

Authors:  Masoumeh Asadbegi; Parichehreh Yaghmaei; Iraj Salehi; Alireza Komaki; Azadeh Ebrahim-Habibi
Journal:  Metab Brain Dis       Date:  2017-03-02       Impact factor: 3.584

3.  Renal tubule ectopic lipid deposition in diabetic kidney disease rat model and in vitro mechanism of leptin intervention.

Authors:  Shasha Liu; Jingjing Da; Jiali Yu; Rong Dong; Jing Yuan; Fuxun Yu; Yan Zha
Journal:  J Physiol Biochem       Date:  2022-02-22       Impact factor: 4.158

Review 4.  Antidiabetic Potential of Monoterpenes: A Case of Small Molecules Punching above Their Weight.

Authors:  Solomon Habtemariam
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

Review 5.  Pharmacological Properties and Molecular Mechanisms of Thymol: Prospects for Its Therapeutic Potential and Pharmaceutical Development.

Authors:  Mohamed Fizur Nagoor Meeran; Hayate Javed; Hasan Al Taee; Sheikh Azimullah; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2017-06-26       Impact factor: 5.810

6.  Thymol mitigates lipopolysaccharide-induced endometritis by regulating the TLR4- and ROS-mediated NF-κB signaling pathways.

Authors:  Haichong Wu; Kangfeng Jiang; Nannan Yin; Xiaofei Ma; Gan Zhao; Changwei Qiu; Ganzhen Deng
Journal:  Oncotarget       Date:  2017-03-21

7.  Thymol polymeric nanoparticle synthesis and its effects on the toxicity of high glucose on OEC cells: involvement of growth factors and integrin-linked kinase.

Authors:  Elahe Karimi; Shahryar Abbasi; Naser Abbasi
Journal:  Drug Des Devel Ther       Date:  2019-07-25       Impact factor: 4.162

8.  Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy.

Authors:  Kun Liu; Shiju Zhou; Jinyan Liu; Yingying Wang; Fengxian Zhu; Man Liu
Journal:  Drug Des Devel Ther       Date:  2019-08-29       Impact factor: 4.162

9.  Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic colorectal cancer.

Authors:  Giuseppe Cicero; Rossella De Luca; Francesco Dieli
Journal:  Onco Targets Ther       Date:  2018-05-24       Impact factor: 4.147

Review 10.  Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.

Authors:  Lucas Opazo-Ríos; Sebastián Mas; Gema Marín-Royo; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.